Purpose of External Fetal Monitoring During Labor
External fetal monitoring was developed to screen for fetal hypoxia during labor by continuously assessing fetal heart rate patterns, though its primary proven benefit is reducing neonatal seizures rather than preventing cerebral palsy or neonatal death. 1
Primary Screening Function
External electronic fetal monitoring (EFM) serves as a screening tool to detect signs of fetal compromise during labor by tracking:
- Baseline fetal heart rate (normal: 110-160 beats per minute) 1
- Heart rate variability (presence indicates adequate fetal oxygenation) 1
- Accelerations (increases in heart rate suggesting fetal well-being) 1
- Decelerations (decreases that may indicate hypoxia or cord compression) 1
- Uterine contraction patterns and their relationship to fetal heart rate changes 1
Evidence-Based Outcomes
The actual clinical benefits of continuous EFM are limited and specific:
- Reduces neonatal seizures (NNT = 661) - the only demonstrable benefit 1
- Does NOT reduce cerebral palsy rates 1
- Does NOT reduce neonatal mortality 1
- Increases cesarean delivery rates (NNH = 20) 1
- Increases operative vaginal deliveries (NNH = 33) 1
Clinical Application Algorithm
For low-risk pregnancies: Structured intermittent auscultation is equivalent to continuous EFM and preferred, as it reduces operative interventions without compromising neonatal outcomes 1
Continuous EFM is indicated for:
- High-risk pregnancies (preeclampsia, diabetes, post-term, IUGR) 1
- Oxytocin augmentation or induction 1
- Abnormal findings on intermittent auscultation 1
- Maternal fever or chorioamnionitis 1
Interpretation Framework
The National Institute of Child Health and Human Development classification system categorizes tracings into three risk levels 1:
Category I (Normal): Moderate baseline variability, no concerning decelerations - continue current monitoring 1
Category II (Indeterminate): Most common pattern; includes minimal variability, tachycardia, or isolated decelerations - requires intrauterine resuscitation measures (maternal repositioning, oxygen, IV fluids, discontinue oxytocin) 1
Category III (Abnormal): Absent variability with recurrent decelerations or bradycardia - expedite delivery 1
Critical Limitations
The false-positive rate of continuous EFM is 99% due to the low prevalence of severe hypoxic events, leading to unnecessary interventions 2. Significant inter-observer variability in interpretation further compromises its reliability 1. This explains why widespread EFM use has increased operative delivery rates without improving long-term neurological outcomes 1.
Common Pitfall
Avoid routine admission EFM tracings in low-risk pregnancies - they increase interventions (epidural use NNH = 19, continuous EFM NNH = 7) without improving neonatal outcomes 1. The decision between continuous EFM and structured intermittent auscultation should be discussed prenatally and based on actual risk factors, not medicolegal concerns 1.